Millennium Management Amends Gossamer Bio Stake

Ticker: GOSS · Form: SC 13G/A · Filed: 2024-01-11T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, amendment, form-13g, biotech

TL;DR

**Millennium Management updated its stake in Gossamer Bio, showing continued institutional interest.**

AI Summary

Millennium Management LLC, a Delaware-based investment firm, filed an amended SC 13G/A on January 11, 2024, disclosing its ownership of Gossamer Bio, Inc. common stock as of December 31, 2023. This amendment indicates a change in their beneficial ownership, which is important because large institutional holdings can influence stock stability and investor confidence. For current or potential shareholders of Gossamer Bio, this filing shows that a significant institutional investor is still involved with the company, providing a potential signal of continued interest.

Why It Matters

This filing shows a major institutional investor's updated position in Gossamer Bio, which can signal confidence or a shift in strategy, potentially influencing other investors.

Risk Assessment

Risk Level: low — This filing is an amendment to a previous disclosure, indicating a routine update rather than a new, unexpected event.

Analyst Insight

Investors should note that a major institutional investor, Millennium Management LLC, continues to hold a position in Gossamer Bio, Inc. This update doesn't indicate a significant change in strategy but confirms ongoing institutional interest. Further investigation into the specific change in share count (not provided in this excerpt) would be necessary to gauge the full impact.

Key Players & Entities

FAQ

What type of filing is this and what does it signify?

This is an SC 13G/A filing, which is an amendment to a Schedule 13G. It signifies that Millennium Management LLC is updating its previous disclosure regarding its beneficial ownership of common stock in Gossamer Bio, Inc. as of December 31, 2023.

Who is the reporting entity in this filing?

The reporting entity is Millennium Management LLC, a company incorporated in Delaware with a business address at 399 Park Avenue, New York, NY 10022.

What is the subject company of this filing?

The subject company is Gossamer Bio, Inc., a pharmaceutical preparations company with a Central Index Key (CIK) of 0001728117, located at 3013 Science Park, San Diego, CA 92121.

What is the CUSIP number for the securities discussed in this filing?

The CUSIP number for the common stock of Gossamer Bio, Inc. is 38341P102.

When was this amendment filed and what was the 'date of event'?

This amendment was filed on January 11, 2024, and the 'date of event which requires filing of this statement' was December 31, 2023.

Filing Stats: 1,543 words · 6 min read · ~5 pages · Grade level 10.2 · Accepted 2024-01-11 16:09:42

Key Financial Figures

Filing Documents

If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is

Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a: (a) o Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) o Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) o Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) o Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) o An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) o An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); CUSIP No. 38341P102 SCHEDULE 13G Page 6 of 10 (g) o A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) o Group, in accordance with 240.13d-1(b)(1)(ii)(J).

Ownership

Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned: See response to Item 9 on each cover page. (b) Percent of Class: See response to Item 11 on each cover page. (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote See response to Item 5 on each cover page. CUSIP No. 38341P102 SCHEDULE 13G Page 7 of 10 (ii) Shared power to vote or to direct the vote See response to Item 6 on each cover page. (iii) Sole power to dispose or to direct the disposition of See response to Item 7 on each cover page. (iv) Shared power to dispose or to direct the disposition of See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following þ .

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable.

Identification and Classification of the Subsidiary Which Acquired

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group See Exhibit I.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group Not applicable.

Certification

Item 10. Certification By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. CUSIP No. 38341P102 SCHEDULE 13G Page 8 of 10 Exhibits: Exhibit I: Joint Filing Agreement, dated as of January 10, 2024, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander. CUSIP No. 38341P102 SCHEDULE 13G Page 9 of 10 SIGNATURE After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct. Dated: January 10, 2024 MILLENNIUM MANAGEMENT LLC By: /s/Gil Raviv Name: Gil Raviv Title: Global General Counsel MILLENNIUM GROUP MANAGEMENT LLC By: /s/Gil Raviv Name: Gil Raviv Title: Global General Counsel /s/ Israel A. Englander Israel A. Englander CUSIP No. 38341P102 SCHEDULE 13G Page 10 of 10 EXHIBIT I JOINT FILING AGREEMENT This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.0001 per share, of Gossamer Bio, Inc. will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Dated: January 10, 2024 MILLENNIUM MANAGEMENT LLC By: /s/Gil Ra

View on Read The Filing